Physician profile
Duane Dh Pitt
NPI 1376529255
$7,743.07
in general payments reported to CMS, 2019-2025
13 companies · $72.30 in 2025
The $72.30 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $259 · 2021: $816 · 2022: $529 · 2023: $5,400 · 2024: $466 · 2025: $72.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,400 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,400.00 |
| Food and Beverage | $538.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $5,412.44 | 2022-2023 | Actastim-S |
| Medacta USA, INC. | $758.02 | 2019-2022 | |
| Medtronic, INC. | $435.77 | 2022-2024 | Infinity Occipitocervical Upper Thoracic System, Cd Horizon Spinal System |
| Abbott Laboratories | $314.80 | 2021 | |
| Stryker Corporation | $313.45 | 2020-2025 | Chesapeake Stabilization System, Monterey Al, Everest Spinal System |
| Bioventus LLC | $203.94 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Misonix INC | $120.48 | 2021 | |
| Boston Scientific Corporation | $56.36 | 2025 | Intracept |
| Zimvie INC. | $48.43 | 2022 | |
| Life Spine, INC. | $25.47 | 2021 | |
| Providence Medical Technology, INC. | $21.92 | 2022 | |
| Arteriocyte Medical Systems, INC. | $17.39 | 2021 | |
| Baxter Healthcare | $14.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Pitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.